{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T11:21:28Z","timestamp":1785842488242,"version":"3.56.0"},"reference-count":47,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2013,3,1]],"date-time":"2013-03-01T00:00:00Z","timestamp":1362096000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,3,1]],"date-time":"2013-03-01T00:00:00Z","timestamp":1362096000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2013,3,1]],"date-time":"2013-03-01T00:00:00Z","timestamp":1362096000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["international-journal-of-gynecological-cancer.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Gynecological Cancer"],"published-print":{"date-parts":[[2013,3]]},"DOI":"10.1097\/igc.0b013e3182849dba","type":"journal-article","created":{"date-parts":[[2013,2,2]],"date-time":"2013-02-02T04:45:07Z","timestamp":1359780307000},"page":"417-421","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":35,"title":["Risk-Reducing Salpingectomy as Preventative Strategy for Pelvic Serous Cancer"],"prefix":"10.1016","volume":"23","author":[{"given":"Charles K.","family":"Anderson","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shannon","family":"Wallace","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maryam","family":"Guiahi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeanelle","family":"Sheeder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kian","family":"Behbakht","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Monique A.","family":"Spillman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1097\/IGC.0b013e3182849dba_bb0005","doi-asserted-by":"crossref","first-page":"35","DOI":"10.3121\/cmr.2007.702","article-title":"Lessons from BRCA: the tubal fimbria emerges as an origin for pelvic serous cancer","volume":"5","author":"Crum","year":"2007","journal-title":"Clin Med Res."},{"key":"10.1097\/IGC.0b013e3182849dba_bb0010","doi-asserted-by":"crossref","first-page":"4160","DOI":"10.1200\/JCO.2008.16.4814","article-title":"Serous tubal intraepithelial carcinoma: its potential role in primary peritoneal serous carcinoma and serous cancer prevention","volume":"26","author":"Carlson","year":"2008","journal-title":"J Clin Oncol."},{"key":"10.1097\/IGC.0b013e3182849dba_bb0015","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/j.ygyno.2009.01.013","article-title":"Precursors to pelvic serous carcinoma and their clinical implications","volume":"113","author":"Folkins","year":"2009","journal-title":"Gynecol Oncol."},{"key":"10.1097\/IGC.0b013e3182849dba_bb0020","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1097\/GCO.0b013e328011a21f","article-title":"The distal fallopian tube: a new model for pelvic serous carcinogenesis","volume":"19","author":"Crum","year":"2007","journal-title":"Curr Opin Obstet Gynecol."},{"key":"10.1097\/IGC.0b013e3182849dba_bb0025","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1097\/01.pas.0000213335.40358.47","article-title":"Intraepithelial carcinoma of the fimbria and pelvic serous carcinoma: Evidence for a causal relationship","volume":"31","author":"Kindelberger","year":"2007","journal-title":"Am J Surg Pathol."},{"key":"10.1097\/IGC.0b013e3182849dba_bb0030","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1006\/gyno.1998.5267","article-title":"Carcinoma of the fallopian tube: a clinicopathological study of 105 cases with observations on staging and prognostic factors","volume":"72","author":"Alvarado-Cabrero","year":"1999","journal-title":"Gynecol Oncol."},{"key":"10.1097\/IGC.0b013e3182849dba_bb0035","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1097\/00000478-200006000-00004","article-title":"Minimal uterine serous carcinoma: diagnosis and clinicopathologic correlation","volume":"24","author":"Wheeler","year":"2000","journal-title":"Am J Surg Pathol."},{"key":"10.1097\/IGC.0b013e3182849dba_bb0040","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1016\/j.ajog.2010.05.038","article-title":"Does bilateral salpingectomy with ovarian retention warrant consideration as a temporary bridge to risk-reducing bilateral oophorectomy in BRCA1\/2 mutation carriers?","volume":"204","author":"Greene","year":"2011","journal-title":"Am J Obstet Gynecol."},{"key":"10.1097\/IGC.0b013e3182849dba_bb0045","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1097\/01.pgp.0000101083.35393.cd","article-title":"Histopathology, FIGO stage, and BRCA mutation status of ovarian cancers from the Gilda Radner Familial Ovarian Cancer Registry","volume":"23","author":"Werness","year":"2004","journal-title":"Int J Gynecol Pathol."},{"key":"10.1097\/IGC.0b013e3182849dba_bb0050","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.ygyno.2012.06.015","article-title":"Tubal epithelial lesions in salpingo-oophorectomy specimens of BRCA-mutation carriers and controls","volume":"127","author":"Mingels","year":"2012","journal-title":"Gynecol Oncol."},{"key":"10.1097\/IGC.0b013e3182849dba_bb0055","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1097\/AOG.0b013e3181a106d4","article-title":"ACOG practice bulletin no. 103: hereditary breast and ovarian cancer syndrome","volume":"113","author":"ACOG","year":"2009","journal-title":"Obstet Gynecol."},{"key":"10.1097\/IGC.0b013e3182849dba_bb0060","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/S1470-2045(06)70983-4","article-title":"Reproductive risk factors for ovarian cancer in carriers of BRCA1 or BRCA2 mutations: a case-control study","volume":"8","author":"McLaughlin","year":"2007","journal-title":"Lancet Oncol."},{"key":"10.1097\/IGC.0b013e3182849dba_bb0065","doi-asserted-by":"crossref","first-page":"1773","DOI":"10.1093\/jnci\/94.23.1773","article-title":"Oral contraceptives and the risk of breast cancer in BRCA1 and BRCA2 mutation carriers","volume":"94","author":"Narod","year":"2002","journal-title":"J Natl Cancer Inst."},{"key":"10.1097\/IGC.0b013e3182849dba_bb0070","doi-asserted-by":"crossref","first-page":"3831","DOI":"10.1200\/JCO.2007.11.1179","article-title":"Oral contraceptives and breast cancer risk in the international BRCA1\/2 carrier cohort study: a report from EMBRACE, GENEPSO, GEO-HEBON, and the IBCCS Collaborating Group","volume":"25","author":"Brohet","year":"2007","journal-title":"J Clin Oncol."},{"key":"10.1097\/IGC.0b013e3182849dba_bb0075","doi-asserted-by":"crossref","first-page":"1467","DOI":"10.1016\/S0140-6736(00)04642-0","article-title":"Tubal ligation and risk of ovarian cancer in carriers of BRCA1 or BRCA2 mutations: a case-control study","volume":"357","author":"Narod","year":"2001","journal-title":"Lancet."},{"key":"10.1097\/IGC.0b013e3182849dba_bb0080","doi-asserted-by":"crossref","first-page":"1072","DOI":"10.1093\/jnci\/95.14.1072","article-title":"Gynecologic surgeries and risk of ovarian cancer in women with BRCA1 and BRCA2 Ashkenazi founder mutations: an Israeli population-based case-control study","volume":"95","author":"Rutter","year":"2003","journal-title":"J Natl Cancer Inst."},{"key":"10.1097\/IGC.0b013e3182849dba_bb0085","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.ygyno.2005.06.065","article-title":"Clinical and pathologic findings of prophylactic salpingo-oophorectomies in 159 BRCA1 and BRCA2 carriers","volume":"100","author":"Finch","year":"2006","journal-title":"Gynecol Oncol."},{"key":"10.1097\/IGC.0b013e3182849dba_bb0090","doi-asserted-by":"crossref","first-page":"2921","DOI":"10.1200\/JCO.2007.11.3449","article-title":"Risk-reducing salpingo-oophorectomy in patients with germline mutations in BRCA1 or BRCA2","volume":"25","author":"Kauff","year":"2007","journal-title":"J Clin Oncol."},{"key":"10.1097\/IGC.0b013e3182849dba_bb0095","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/S1470-2045(06)70585-X","article-title":"Mortality after bilateral salpingo-oophorectomy in BRCA1 and BRCA2 mutation carriers: a prospective cohort study","volume":"7","author":"Domchek","year":"2006","journal-title":"Lancet Oncol."},{"key":"10.1097\/IGC.0b013e3182849dba_bb0100","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1001\/jama.296.2.185","article-title":"Salpingo-oophorectomy and the risk of ovarian, fallopian tube, and peritoneal cancers in women with a BRCA1 or BRCA2 Mutation","volume":"296","author":"Finch","year":"2006","journal-title":"JAMA."},{"key":"10.1097\/IGC.0b013e3182849dba_bb0105","doi-asserted-by":"crossref","first-page":"1331","DOI":"10.1200\/JCO.2007.13.9626","article-title":"Risk-reducing salpingo-oophorectomy for the prevention of BRCA1- and BRCA2-associated breast and gynecologic cancer: a multicenter, prospective study","volume":"26","author":"Kauff","year":"2008","journal-title":"J Clin Oncol."},{"key":"10.1097\/IGC.0b013e3182849dba_bb0110","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1093\/jnci\/djn442","article-title":"Meta-analysis of risk reduction estimates associated with risk-reducing salpingo-oophorectomy in BRCA1 or BRCA2 mutation carriers","volume":"101","author":"Rebbeck","year":"2009","journal-title":"J Natl Cancer Inst."},{"key":"10.1097\/IGC.0b013e3182849dba_bb0115","doi-asserted-by":"crossref","first-page":"10332","DOI":"10.1523\/JNEUROSCI.3369-06.2006","article-title":"Estrogen, menopause, and the aging brain: how basic neuroscience can inform hormone therapy in women","volume":"26","author":"Morrison","year":"2006","journal-title":"J Neurosci."},{"key":"10.1097\/IGC.0b013e3182849dba_bb0120","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/S0090-8258(03)00072-6","article-title":"Quality of life in women at risk for ovarian cancer who have undergone risk-reducing oophorectomy","volume":"89","author":"Robson","year":"2003","journal-title":"Gynecol Oncol."},{"key":"10.1097\/IGC.0b013e3182849dba_bb0125","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1146\/annurev.med.53.082901.103925","article-title":"Breast cancer risk reduction: strategies for women at increased risk","volume":"53","author":"Chlebowski","year":"2002","journal-title":"Annu Rev Med."},{"key":"10.1097\/IGC.0b013e3182849dba_bb0130","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1258\/mi.2008.008016","article-title":"Prophylactic oophorectomy in premenopausal women and long-term health","volume":"14","author":"Shuster","year":"2008","journal-title":"Menopause Int."},{"key":"10.1097\/IGC.0b013e3182849dba_bb0135","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1016\/j.brainres.2010.10.031","article-title":"Oophorectomy, menopause, estrogen treatment, and cognitive aging: clinical evidence for a window of opportunity","volume":"1379","author":"Rocca","year":"2011","journal-title":"Brain Res."},{"key":"10.1097\/IGC.0b013e3182849dba_bb0140","doi-asserted-by":"crossref","first-page":"1475","DOI":"10.1093\/jnci\/91.17.1475","article-title":"Breast cancer risk after bilateral prophylactic oophorectomy in BRCA1 mutation carriers","volume":"91","author":"Rebbeck","year":"1999","journal-title":"J Natl Cancer Inst."},{"key":"10.1097\/IGC.0b013e3182849dba_bb0145","doi-asserted-by":"crossref","first-page":"7491","DOI":"10.1200\/JCO.2004.00.7138","article-title":"Breast cancer risk following bilateral oophorectomy in BRCA1 and BRCA2 mutation carriers: an international case-control study","volume":"23","author":"Eisen","year":"2005","journal-title":"J Clin Oncol."},{"key":"10.1097\/IGC.0b013e3182849dba_bb0150","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1016\/S0140-6736(04)15493-7","article-title":"HABITS (hormonal replacement therapy after breast cancerVis it safe?), a randomised comparison: trial stopped","volume":"363","author":"Holmberg","year":"2004","journal-title":"Lancet."},{"key":"10.1097\/IGC.0b013e3182849dba_bb0155","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1038\/ng0197-103","article-title":"Variation of risks of breast and ovarian cancer associated with different germline mutations of the BRCA2 gene","volume":"15","author":"Gayther","year":"1997","journal-title":"Nat Genet."},{"key":"10.1097\/IGC.0b013e3182849dba_bb0160","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1086\/318181","article-title":"Variation in cancer risks, by mutation position, in BRCA2 mutation carriers","volume":"68","author":"Thompson","year":"2001","journal-title":"Am J Hum Genet."},{"key":"10.1097\/IGC.0b013e3182849dba_bb0165","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1186\/1757-2215-5-13","article-title":"Tubal ligation, hysterectomy and ovarian cancer: a meta-analysis","volume":"5","author":"Rice","year":"2012","journal-title":"J Ovarian Res."},{"key":"10.1097\/IGC.0b013e3182849dba_bb0170","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1093\/humupd\/dmq030","article-title":"Tubal ligation and the risk of ovarian cancer: review and meta-analysis","volume":"17","author":"Cibula","year":"2011","journal-title":"Hum Reprod Update."},{"key":"10.1097\/IGC.0b013e3182849dba_bb0175","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1093\/aje\/kwh284","article-title":"Relation of contraceptive and reproductive history to ovarian cancer risk in carriers and noncarriers of BRCA1 gene mutations","volume":"160","author":"McGuire","year":"2004","journal-title":"Am J Epidemiol."},{"key":"10.1097\/IGC.0b013e3182849dba_bb0180","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1158\/1055-9965.EPI-08-0546","article-title":"Reproductive and hormonal factors, and ovarian cancer risk for BRCA1 and BRCA2 mutation carriers: results from the International BRCA1\/2 Carrier Cohort Study","volume":"18","author":"Antoniou","year":"2009","journal-title":"Cancer Epidemiol Biomarkers Prev."},{"key":"10.1097\/IGC.0b013e3182849dba_bb0185","doi-asserted-by":"crossref","first-page":"562","DOI":"10.6004\/jnccn.2010.0043","article-title":"Genetic\/familial high-risk assessment: breast and ovarian","volume":"8","author":"Daly","year":"2010","journal-title":"J Natl Compr Canc Netw."},{"key":"10.1097\/IGC.0b013e3182849dba_bb0190","first-page":"265","article-title":"Breast and ovarian cancer incidence in BRCA1-mutation carriers. Breast Cancer Linkage Consortium","volume":"56","author":"Easton","year":"1995","journal-title":"Am J Hum Genet."},{"key":"10.1097\/IGC.0b013e3182849dba_bb0195","doi-asserted-by":"crossref","first-page":"S5","DOI":"10.1111\/j.1524-4741.2004.101S3.x","article-title":"Efficacy of risk-reducing salpingo-oophorectomy in women with BRCA-1 and BRCA-2 mutations","volume":"10","author":"Olopade","year":"2004","journal-title":"Breast J."},{"key":"10.1097\/IGC.0b013e3182849dba_bb0200","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1056\/NEJM199703133361104","article-title":"The risk of ectopic pregnancy after tubal sterilization. U.S. Collaborative Review of Sterilization Working Group","volume":"336","author":"Peterson","year":"1997","journal-title":"N Engl J Med."},{"key":"10.1097\/IGC.0b013e3182849dba_bb0205","first-page":"CR24","article-title":"Hysterectomy surveillance in the United States, 1997 through 2005","volume":"14","author":"Merrill","year":"2008","journal-title":"Med Sci Monit."},{"key":"10.1097\/IGC.0b013e3182849dba_bb0210","first-page":"681","article-title":"Ovarian cancer in women with prior hysterectomy: a 14-year experience at the University of Miami","volume":"78","author":"Sightler","year":"1991","journal-title":"Obstet Gynecol."},{"key":"10.1097\/IGC.0b013e3182849dba_bb0215","first-page":"1629","article-title":"National survey of ovarian carcinoma. I. A patient care evaluation study of the American College of Surgeons","volume":"71","author":"Averette","year":"1993","journal-title":"Cancer."},{"key":"10.1097\/IGC.0b013e3182849dba_bb0220","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1111\/IGC.0b013e318199009c","article-title":"The fallopian tube: primary site of most pelvic high-grade serous carcinomas","volume":"19","author":"Salvador","year":"2009","journal-title":"Int J Gynecol Cancer."},{"key":"10.1097\/IGC.0b013e3182849dba_bb0225","doi-asserted-by":"crossref","first-page":"2918","DOI":"10.1016\/S0015-0282(00)00481-7","article-title":"Tubal sterilization: focus on the U.S. experience","volume":"73","author":"Westhoff","year":"2000","journal-title":"Fertil Steril."},{"key":"10.1097\/IGC.0b013e3182849dba_bb0230","unstructured":"Fast Stats: An interactive tool for access to SEER cancer statistics. Surveillance Research Program, National Cancer Institute. Available at: http:\/\/seer.cancer.gov\/faststats. Accessed April, 2012."},{"key":"10.1097\/IGC.0b013e3182849dba_bb0235","doi-asserted-by":"crossref","first-page":"2918","DOI":"10.1093\/humrep\/der274","article-title":"The post-reproductive Fallopian tube: better removed?","volume":"26","author":"Dietl","year":"2011","journal-title":"Hum Reprod."}],"container-title":["International Journal of Gynecological Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1048891X24018863?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1048891X24018863?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1097\/IGC.0b013e3182849dba","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,23]],"date-time":"2025-07-23T01:13:09Z","timestamp":1753233189000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1048891X24018863"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,3]]},"references-count":47,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2013,3]]}},"alternative-id":["S1048891X24018863"],"URL":"https:\/\/doi.org\/10.1097\/igc.0b013e3182849dba","relation":{},"ISSN":["1048-891X"],"issn-type":[{"value":"1048-891X","type":"print"}],"subject":[],"published":{"date-parts":[[2013,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Risk-Reducing Salpingectomy as Preventative Strategy for Pelvic Serous Cancer","name":"articletitle","label":"Article Title"},{"value":"International Journal of Gynecological Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1097\/IGC.0b013e3182849dba","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright Copyright \u00a9 2013 by IGCS and ESGO","name":"copyright","label":"Copyright"}]}}